-
Management of Enfuvirtide Injection-Site Reactions
Most patients who inject this HIV fusion inhibitor as part
of their HAART regimen experience mild-to-moderate
localized skin reactions.
Medscape HIV/AIDS, October 2003
-
Once-Daily HAART: The Shape of Things to Come
Simplication of antiretroviral therapy is one of the major
trends in HIV management, with once-daily drugs and
regimens a key component.
Medscape HIV/AIDS, October 2003
-
Viral Load Monitoring in Resource-Limited Settings
How should viral load be measured in settings where
these assays are beyond the financial reach of most
patients?
Medscape HIV/AIDS, September 2003
-
Boosted-PI Regimen Following NNRTI Failure
With the advantages and disadvantages associated
with each boosted PI, tailoring treatment to the patient
remains key.
Medscape HIV/AIDS, September 2003
-
Switching Viral Load Assays
When a lab uses a new viral load assay, results may
vary for any number of reasons.
Medscape HIV/AIDS, August 2003
-
Decreasing CD4+ Cell Count in a Patient With Controlled Viremia and Other Comorbidities
The patient has declining CD4+ cell count and
undetectable HIV RNA, but polypharmacy and
comorbidities complicate the differential diagnosis.
Medscape HIV/AIDS, July 2003
-
CNS Penetration of Antiretroviral Drugs
A treatment regimen with the best likelihood of
controlling HIV RNA in both plasma and CSF may
optimize therapeutic outcome.
Medscape Neurology & Neurosurgery, July 2003
-
Elevated CPK Following Fibrate Therapy and Chiropractic Care
A female patient with HIV, treated with HAART and a
fibrate, developed persistently elevated CPK following a
chiropractic adjustment. Aggressive IV hydration has
not shown results.
Medscape HIV/AIDS, June 2003
-
Perinatal Treatment Resistance and Future Treatment Options
How will mothers who develop nevirapine resistance
perinatally be likely to respond to future antiretroviral
regimens of nevirapine/zidovudine/lamivudine?
Medscape HIV/AIDS, January 2003
-
Is Abacavir/Zidovudine/Lamivudine Appropriate for First-line Antiretroviral Therapy?
Is Trizivir appropriate for initiating HAART in a
28-year-old male patient with a viral load of 25,000
copies/mL and a CD4+ cell count of 295 cells/mm3?
Medscape HIV/AIDS, December 2002
-
Suppressive or Episodic Therapy for Recurrent Herpetic Ulcers?
Is suppressive therapy with antiherpetic drugs
recommended for an HIV-infected individual with
recurrent debilitating oral ulcers, or is it preferable to
treat each episode?
Medscape HIV/AIDS, December 2002
-
Use T-20 as Single New Agent for Experienced Patients?
I have a number of patients who are resistant to all
currently available antiretrovirals, with low CD4+ cell
counts. Is there likely to be any value in adding T-20
now as a single new drug?
Medscape HIV/AIDS, December 2002
-
Combining Saquinavir With Lopinavir/Ritonavir?
What is the current dose(s) suggested for combining lopinavir/ritonavir with saquinavir?
Medscape HIV/AIDS, October 2002
-
Clinical Role of HIV Replication Capacity Assay?
It is now possible to obtain information on the replicative capacity of patient virus, but how should we use this information when making treatment decisions?
Medscape HIV/AIDS, September 2002
-
Adjunctive Antiretrovirals for HIV-Infected Patient With Neurosyphilis?
Is HAART beneficial as adjunctive treatment in addition to specific antitreponemal antibiotics?
Medscape HIV/AIDS, September 2002
-
Significance of HIV/HTLV Coinfection?
What is the significance of a positive screen for HTLV-1 or HTLV-2 in an HIV-infected individual?
Medscape HIV/AIDS, September 2002
-
Second-line Regimen for Relapsed AIDS-Related Lymphoma?
What is the best second-line treatment for relapsed,
diffuse, large-cell non-Hodgkin's lymphoma in an AIDS
patient?
Medscape HIV/AIDS, August 2002
-
Outbreaks of Oral Warts Coinciding With HAART?
How should we manage an HIV+ patient who has severe outbreaks of oral warts during HAART which disappear off-therapy?
Medscape HIV/AIDS, July 2002
-
Once-Daily Regimen for Naive Patient With High HIV Viral Load?
What is a good once-daily regimen for an antiretroviral-naive patient with a low CD4+ cell count and high viral load?
Medscape HIV/AIDS, July 2002
-
Zidovudine/Lamivudine for Pregnant Woman With Low HIV Viral Load?
Is it really necessary to use a third agent in a treatment-naive pregnant woman with a low baseline viral load?
Medscape HIV/AIDS, June 2002
